Schroeder T, Stelljes M, Christopeit M, Esseling E, Scheid C, Mikesch J-H, Rautenberg C, Jäger P, Cadeddu R-P, Drusenheimer N, Holtick U, Klein S, Trenschel R, Haas R, Germing U, Kröger N, Kobbe G. Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial. haematol [Internet]. 2023Nov.1 [cited 2024May2];108(11):3001-10. Available from: https://haematologica.org/article/view/haematol.2022.282570